NCT00538525已完成不适用
Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 主要终点
- Effectiveness
研究概览
简要总结
Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with locally advanced breast cancer
排除标准
- •Patients with metastatic breast cancer
研究组 & 干预措施
Arm 1
Active Comparator
Doxorubicin, Docetaxel, Cisplatin
干预措施: Doxorubicin, Docetaxel, Cisplatin (Drug)
结局指标
主要结局
Effectiveness
时间窗: overall
次要结局
未报告次要终点
研究者
相似试验
已完成
2 期
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast CancerBreast CancerMetastatic Breast CancerNCT00404066George Albert Fisher21
已完成
2 期
Phase II Study of Docetaxel Plus CDDP for NSCLC Stage IIINSCLCNCT00172380National Taiwan University Hospital41
Unknown
2 期
Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by SurgeryBreast CancerNCT00801411National Cancer Centre, Singapore318
终止
2 期
Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryLung CancerNCT00293332University of California, San Francisco1
Unknown
2 期
A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell CarcinomaStage II and III Esophageal Squamous Cell CarcinomaNCT02915965Sun Yat-sen University80